FDA Drug Application (203312) for RYTARY by IMPAX LABS INC

Back to FDA Applications sponsored by IMPAX LABS INC

Application Number203312
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage23.75MG;95MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRYTARY
Active IngredientCARBIDOPA; LEVODOPA



Back to FDA Applications sponsored by IMPAX LABS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.